GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NovaBay Pharmaceuticals Inc (AMEX:NBY) » Definitions » E10
中文

NovaBay Pharmaceuticals (NovaBay Pharmaceuticals) E10

: $-84.54 (As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

NovaBay Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.816. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-84.54 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 19.20% per year. During the past 5 years, the average E10 Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of NovaBay Pharmaceuticals was 22.50% per year. The lowest was 3.20% per year. And the median was 12.60% per year.

As of today (2024-04-24), NovaBay Pharmaceuticals's current stock price is $0.077. NovaBay Pharmaceuticals's E10 for the quarter that ended in Dec. 2023 was $-84.54. NovaBay Pharmaceuticals's Shiller PE Ratio of today is .


NovaBay Pharmaceuticals E10 Historical Data

The historical data trend for NovaBay Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovaBay Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -175.78 -160.03 -145.84 -128.26 -84.54

NovaBay Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -128.26 -118.04 -106.87 -96.35 -84.54

Competitive Comparison

For the Biotechnology subindustry, NovaBay Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NovaBay Pharmaceuticals Shiller PE Ratio Distribution

For the Biotechnology industry and Healthcare sector, NovaBay Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NovaBay Pharmaceuticals's Shiller PE Ratio falls into.



NovaBay Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NovaBay Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.816/129.4194*129.4194
=-0.816

Current CPI (Dec. 2023) = 129.4194.

NovaBay Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201403 -70.000 99.695 -90.871
201406 -52.500 100.560 -67.567
201409 -70.000 100.428 -90.208
201412 -75.250 99.070 -98.303
201503 -74.550 99.621 -96.849
201506 -64.400 100.684 -82.780
201509 -61.950 100.392 -79.863
201512 -39.900 99.792 -51.746
201603 -43.400 100.470 -55.905
201606 -12.600 101.688 -16.036
201609 -11.900 101.861 -15.120
201612 -3.778 101.863 -4.800
201703 -9.100 102.862 -11.449
201706 -3.850 103.349 -4.821
201709 -5.600 104.136 -6.960
201712 2.100 104.011 2.613
201803 -4.900 105.290 -6.023
201806 -4.200 106.317 -5.113
201809 -3.850 106.507 -4.678
201812 -3.150 105.998 -3.846
201903 -8.750 107.251 -10.559
201906 -4.900 108.070 -5.868
201909 -0.700 108.329 -0.836
201912 -4.200 108.420 -5.013
202003 -2.100 108.902 -2.496
202006 -5.250 108.767 -6.247
202009 -2.800 109.815 -3.300
202012 -1.050 109.897 -1.237
202103 -1.400 111.754 -1.621
202106 -1.400 114.631 -1.581
202109 -1.750 115.734 -1.957
202112 -0.710 117.630 -0.781
202203 -0.080 121.301 -0.085
202206 -1.430 125.017 -1.480
202209 -3.610 125.227 -3.731
202212 -4.780 125.222 -4.940
202303 -0.850 127.348 -0.864
202306 -1.270 128.729 -1.277
202309 -0.370 129.860 -0.369
202312 -0.816 129.419 -0.816

Add all the adjusted EPS together and divide 10 will get our e10.


NovaBay Pharmaceuticals  (AMEX:NBY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


NovaBay Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of NovaBay Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


NovaBay Pharmaceuticals (NovaBay Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
2000 Powell Street, Suite 1150, Emeryville, CA, USA, 94608
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Executives
Tommy Law officer: Interim CFO 2000 POWELL STREET, SUITE 1150, EMERYVILLE CA 94608
Jeffrey Kunin officer: President, DERMAdoctor, LLC 4346 BELGIUM BLVD NW, RIVERSIDE MO 64150
Audrey Kunin officer: Chief Product Officer 4346 BELGIUM BLVD NW, RIVERSIDE MO 64150
Justin Hall officer: General Counsel 5980 HORTON STREET, SUITE 550, EMERYVILLE CA 94608
Yongxiang Zheng director NO.10, UNIT 1, LIJING VILLA, TIANZHU, SHUNYI DISTRICT, BEIJING F4 101316
Julie Garlikov director 2420 17TH STREET, SUITE 220, DENVER CO 80202
Andrew D. Jones officer: CFO and Treasurer 2000 POWELL STREET, SUITE 1150, EMERYVILLE CA 94608
Mijia Wu director SUITE 6C, BLDG 3, YOU YOU CENTURY PLAZA, NO 428 YANG GAO SOUTH ROAD, SHANGHAI F4 CHINA
Jian Ping Fu 10 percent owner LEVEL 1, BLDG 1, GREENWOOD BUSINESS PARK, 301 BURWOOD HWY, BURWOOD C3 3125
Wang Xu officer: NEO - Sr Mgr and Controller 2000 POWELL STREET, SUITE 1150, EMERYVILLE CA 94608
Swan Sit director 95 JACKSON STREET, NEWTON MA 02459
Yenyou Zheng director 1055 WEST HASTINGS STREET, SUITE 1980, VANCOUVER A1 V6E 2E9
Xiaopei Wang director 2/44 FRANKLIN ROAD, DONCASTER EAST C3 3109
Jason Philip Raleigh officer: Interim CFO and Treasurer 2000 POWELL STREET, SUITE 1150, EMERYVILLE CA 94608
Pioneer Pharma (hong Kong) Co Ltd 10 percent owner FLAT 2605, 26/F TRENDY CENTRE, 682 CASTLE PEAK ROAD, KOWLOON K3 000000